NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
551 Örebro |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 9 | 0.2% | 8 | 0.2% | . | . | 1 | 0.0% | . | . | . | . | 1 | 0.0% | 4524 | 99.6% | 4543 | 100.0% |
ASCUS | 96 | 16.5% | 114 | 19.6% | 1 | 0.2% | 47 | 8.1% | . | . | . | . | 49 | 8.4% | 276 | 47.3% | 583 | 100.0% |
CIN1 | 60 | 16.7% | 112 | 31.1% | 1 | 0.3% | 66 | 18.3% | 2 | 0.6% | . | . | 21 | 5.8% | 98 | 27.2% | 360 | 100.0% |
Atypical glandular cells/AGC | . | . | . | . | . | . | . | . | 3 | 60.0% | 2 | 40.0% | . | . | . | . | 5 | 100.0% |
Unclear atypia | 7 | 26.9% | 5 | 19.2% | . | . | 9 | 34.6% | 1 | 3.8% | . | . | 3 | 11.5% | 1 | 3.8% | 26 | 100.0% |
ASC-H | . | . | 1 | 25.0% | . | . | 2 | 50.0% | . | . | . | . | 1 | 25.0% | . | . | 4 | 100.0% |
CIN3 | 9 | 7.3% | 14 | 11.4% | 1 | 0.8% | 93 | 75.6% | 3 | 2.4% | 2 | 1.6% | . | . | 1 | 0.8% | 123 | 100.0% |
Total | 181 | 3.2% | 254 | 4.5% | 3 | 0.1% | 218 | 3.9% | 9 | 0.2% | 4 | 0.1% | 75 | 1.3% | 4900 | 86.8% | 5644 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81403 |